|
May 15, 2009 - Global Med Technologies(R), Inc. ("Global Med" or the "Company")
(OTC Bulletin Board: GLOB), an international healthcare information technology
company, today reported profitability and its tenth consecutive quarter of
revenue growth for the first quarter ended March 31, 2009.
Global Med's record revenues of $8.359 million for the
first quarter of 2009 represent an increase of $3.766 million or 82% over the
$4.593 million recorded for the comparable 2008 period. In the first
quarter of 2009, operating income improved to $1.057 million from $625 thousand
during the comparable 2008 period. The Company's net income for the first
quarter of 2009 was $321 thousand, or $0.01 per basic common share outstanding,
versus $360 thousand, or $0.01 per basic common share outstanding, for the
comparable 2008 period.
About Global Med Technologies(R), Inc.;
Global Med Technologies, Inc. is an international healthcare information
technology company which develops regulated and non-regulated products and
services for the healthcare industry. As a leading provider of blood and
laboratory systems and services, Global Med's products are deployed in 20
countries and serve over 2,100 transfusion centers, blood banks and laboratory
sites.
Global Med's domestic companies are Wyndgate Technologies(R), a leader in
software products and services for donor centers and hospital transfusion
services; eDonor(R), which offers web-based donor relationship management
systems; and PeopleMed(TM), Inc., which implements cost-effective software
validation, consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer of donor
center and transfusion management systems as well as cellular therapy software,
laboratory information systems and quality assurance medical software systems
internationally.
Contact:
Web Site:
http://www.globalmedtech.com.
Source. |
